Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 225 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Michael D.

United States

USD 225 /hr

Ph. D. Medicinal Chemist | CNS Drug Discovery | Leading Innovative Research in Neurological Disorders

Profile Summary

Passionate Medicinal Chemist with a strong background in organic chemistry and drug discovery. Proficient in designing, synthesizing, and optimizing small molecules for therapeutic applications. Experienced in hit identification, lead optimization, and structure-activity relationship (SAR) analysis. Adept at analytical techniques including spectroscopy, chromatography, and mass spectrometry for compound characterization. Proven track record of contributing to successful drug discovery programs and collaborating effectively with multidisciplinary teams. Committed to advancing science and improving human health through innovative research and development. Open to exciting opportunities in pharmaceutical research, biotechnology, or academia where I can leverage my skills to drive impactful discoveries and bring new therapies to market. “There is so much more to be done; the patients are waiting.” Dr. Paul Janssen

Subject Matter Expertise

• ☆ Chemical Reagent Development
• ☆ Dewatering & Drying Technology
• ☆ Inorganic Chemistry
• ☆ Physical Chemistry
• ☆ Radiochemistry
• ☆ Organometallic Chemistry
• ☆ Peptide Synthesis
• ☆ Data Collection
• ☆ Nutrition Science
• ☆ Food Microbiology
• ☆ Food Preservation
• ☆ Flavor & Fragrance Chemistry
• ☆ Food Chemistry
• ☆ Nutritional Analysis
• ☆ Data Storage
• ☆ Exercise & Fitness
• ☆ Physical Fitness
• ☆ Athletic Training & Coaching
• ☆ Personal Training
• ☆ Men's Interest
• ☆ Drug Discovery
• ☆ High Throughput Screening (HTS)
• ☆ Drug Target Identification
• ☆ Hit-to-Lead & Lead Optimization
• ☆ Medicinal Chemistry
• ☆ Drug Design
• ☆ Structure-Activity Relationship (SAR) Studies
• ☆ Drug Development
• ☆ Drug Formulation
• ☆ Small Molecule Drug Development
• ☆ Biologic & Biosimilar Development
• ☆ Drug Substance Characterization
• ☆ Biosafety Testing
• ☆ Bioanalytical Testing
• ☆ Drug Stability Testing
• ☆ Preclinical ADME/PK/PD
• ☆ Drug-Drug Interactions
• ☆ Preclinical Research
• ☆ Preclinical Pharmacology
• ☆ In vitro Preclinical Toxciology
• ☆ In vivo Preclinical Toxicology
• ☆ Investigational New Drug (IND) Application Consulting
• ☆ Bioavailability
• ☆ Human Biology
• ☆ Psychoactive Drugs

Services

• Writing
• Research
• Consulting
• Product Development

Writing Technical Writing, Creative Writing, Newswriting, Audio Transcription, General Proofreading & Editing

Research Fact Checking, Gray Literature Search, Scientific and Technical Research, Systematic Literature Review, Secondary Data Collection

Consulting Scientific and Technical Consulting

Product Development Formulation, Stability/Shelf Life Testing, Product Evaluation, Product Validation, Quality Assurance & Control (QA/QC), Product Compliance

Work Experience

Senior Researcher

Saint Joseph's University

- Present

Laboratory Manager

Saint Joseph's University

June 2022 - June 2024

Laboratory Manager

University of the Sciences

August 2021 - June 2022

Researcher

University of the Sciences

March 2021 - August 2021

Laboratory Technician

University of the Sciences

August 2020 - March 2021

Education

Doctor of Philosophy (PhD) (Chemistry and Biochemistry)

Saint Joseph's University

June 2022 - May 2023

Doctor of Philosophy (PhD) (Chemistry and Biochemistry)

University of the Sciences

January 2015 - June 2022

Bachelor of Sciences (Chemistry and Biochemistry)

University of the Sciences

August 2010 - May 2014

Certifications

• American Chemical Certification

  ACS

  April 2014 - Present

Publications

DISSERTATION THESIS

Michael Dybek (2023). Structure Activity Relationship (SAR) Studies of 1,2-Diarylethylamines as N-Methyl-D-Aspartate Receptor Antagonists . Structure Activity Relationship (SAR) Studies of 1,2-Diarylethylamines as N-Methyl-D-Aspartate Receptor Antagonists.

JOURNAL ARTICLE

Famojuro TI, Elufioye TO, Olajide OA, Dybek M, Adejare A (2021). New cytotoxic compounds from the leaves of <i>Caesalpinia</i> <i>benthamiana</i> (Baill.) Herend. & Zarucchi (Fabaceae) . Avicenna journal of phytomedicine.

A. D. Ladagu, F. E. Olopade, O. R. Folarin, T. O. Elufioye, J. V. Wallach, M. B. Dybek, James Olopade, A. Adejare (2020). Novel NMDA-receptor antagonists ameliorate vanadium neurotoxicity . Naunyn-Schmiedeberg's Archives of Pharmacology.

Michael Dybek, Jason Wallach, Tristan Colestock, Juli&#224; Agramunt, Matt D.B. Claydon, Nadine Filemban, Muhammad Chatha, Adam L. Halberstadt, Simon D. Brandt, David Lodge, et al. (2019). Pharmacological characterizations of the 'legal high' fluorolintane and isomers . European Journal of Pharmacology.

Michael Dybek, Jason Wallach, Pierce Kavanagh, Tristan Colestock, Nadine Filemban, Dr. Geraldine Dowling, Folker Westphal, Simon Elliott, Adeboye Adejare, Simon D. Brandt (2019). Syntheses and analytical characterizations of the research chemical 1‐[1‐(2‐fluorophenyl)‐2‐phenylethyl]pyrrolidine (fluorolintane) and five of its isomers . Drug Testing and Analysis.

BOOK CHAPTER

Michael Dybek, Anush Abelian, Jason Wallach, Boyenoh Gaye, Adeboye Adejare (2021). Pharmaceutical chemistry . Remington.

PATENT

Michael Dybek Fluorinated Tryptamine Compounds, Analogues Thereof, and Methods Using Same .